New Digital Network to Simplify Process of Achieving DSCSA Compliance The National Association of Boards of Pharmacy® (NABP®) announced today the upcoming launch of Pulse by NABP™, an inclusive, accessible, and secure digital platform that simplifies compliance with the Drug Supply Chain Security Act (DSCSA). With an expected launch in summer 2023, the platform is […]

Read More ›

Shortly before the new year, President Joseph R. Biden signed the Consolidated Appropriations Act for 2023, which includes significant legislation to address the worsening overdose crisis. The National Association of Boards of Pharmacy® (NABP®) applauds the passage of the bill and its Mainstreaming Addiction Treatment Act (MAT Act) provision, which will remove federal barriers to […]

Read More ›

MOUNT PROSPECT, IL – The National Association of Boards of Pharmacy® (NABP®) has released a new report, Disrupting Illegal Online Pharmacies: Lock-and-Suspend as a Tool to Protect Patients, which explores the process and impact of locking and suspending domain names associated with websites that illegally sell prescription medications online. The report explains how lock-and-suspend directly […]

Read More ›

New Network Provides Regulators, Industry With Tool to Further Protect Drug Supply Chain MOUNT PROSPECT, IL – The National Association of Boards of Pharmacy® (NABP®) announced today that it is entering the final phase of development for its new network to facilitate supply chain interoperability. The network will provide a means for state regulators and […]

Read More ›

The National Association of Boards of Pharmacy® (NABP®) is pleased to announce that its Specialty Pharmacy Accreditation has earned recognition from Optum Rx’s Specialty Pharmacy Network. This recognition deems NABP as an approved accrediting organization for pharmacies seeking specialty accreditation to qualify for participation in the Optum Rx Specialty Pharmacy Network.   NABP’s Specialty Pharmacy Accreditation […]

Read More ›

NABP and three other state board associations, have launched the Opioid Regulatory Collaborative (ORC). The ORC will bring together senior leaders from NABP, the American Association of Dental Boards, the Federation of State Medical Boards, and the National Council of State Boards of Nursing to share resources and strategies to slow opioid substance use disorder […]

Read More ›

In June 2020, the National Association of Boards of Pharmacy (NABP) began to further develop a system to gather and share compounding pharmacy information as part of a three-year pilot project with Food and Drug Administration (FDA). Funded by FDA, this project builds upon the existing NABP e-Profile system with the addition of data fields and functionality […]

Read More ›

The National Association of Boards of Pharmacy® (NABP®) continues its call for the passage of the Mainstreaming Addiction Treatment Act to remove barriers that prevent those with opioid use disorder (OUD) from accessing vital, lifesaving addiction treatment. This bipartisan bill was introduced today by Representatives Paul Tonko (D-NY), Michael Turner (R-OH), Antonio Delgado (D-NY), Anthony Gonzalez […]

Read More ›

In the National Association of Boards of Pharmacy® (NABP®) January 2021 Rogue Rx Activity Report, the association focuses on the risk of tainted dietary supplements to consumers. The report, titled Risky Dietary Supplements: How Pharmacists Can Help Protect Patients, explores adulterated dietary supplements that enter the marketplace and how pharmacists are well-positioned to provide consumers with information […]

Read More ›

Emphasizing the role that pharmacists and state boards of pharmacy play in protecting the public health, NABP has sent a letter to congressional leadership urging Congress to continue supporting robust investments in federal programs to combat both the ongoing opioid epidemic and coronavirus disease 2019 (COVID-19) pandemic. Signed by NABP Executive Director/Secretary Lemrey “Al” Carter, […]

Read More ›